The human intestinal microbiome consists of a dynamic multispecies community of trillions of bacteria. Advances in microbiome research over the last two decades revealed that the intestinal microbiome plays a critical role in the host’s innate and adaptive immune system.
To identify the multitude of pathways in which the symbiotic microbiome interacts with the human body is an exceedingly complex undertaking. Though, it also holds the key for game-changing diagnostic and pharmaceutical applications that will be a quantum leap forward for doctors and patients.
We are involved in several clinical studies and cooperate with multiple international universities and top tier hospitals to revolutionize oncological precision medicine.
